» Articles » PMID: 28002485

A Combinatory Antibody-Antigen Microarray Assay for High-Content Screening of Single-Chain Fragment Variable Clones from Recombinant Libraries

Overview
Journal PLoS One
Date 2016 Dec 22
PMID 28002485
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We have developed a combinatory antibody-antigen microarray for direct screening of multiple single-chain fragment variable (scFv) clones with no need for pre-purification or enrichment before screening. The straightforward workflow allows for early selection of binders to predefined peptide and glycopeptide targets. A capture antibody is contact printed on microarray slides, side by side with the antigens of interest. A large number of scFv clones, in supernatants, are printed on top of the capture antibody and the antigen in a "spot-on-spot" print. The printed scFv clones, which bind to the capture antibody, are detected using biotinylated antigen, while the binding of scFv clones to the printed antigen is detected through a mouse anti-tag antibody. Two different analyses are thus performed on the same slide, generating two kinds of information: one on the ability of an individual scFv clone to bind to the soluble form of the antigen, which may favour selection for higher affinity rather than avidity, while the other allows the identification of large numbers of clones, simultaneously, due to the binding of scFv clones to densely presented antigens, thus providing an overall increased hit rate. The functionality of the new screening approach was illustrated through the generation of antibodies against peptides from the chaperone complex Ku70/Ku80 and the GalNAcα-serine/threonine epitope on the IgA1 alpha chain hinge region. In total, 659 scFv clones were screened with a hit rate of approximately 20%. This approach allowed the identification of functional antibodies in both cases, illustrating the usefulness and capacity of this combinatory microarray screening technique for efficient analysis and validation of antibodies at an early stage of antibody generation.

Citing Articles

Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens.

Khan Khilji S, Op t Hoog C, Warschkau D, Luhle J, Goerdeler F, Freitag A Theranostics. 2023; 13(9):3041-3063.

PMID: 37284439 PMC: 10240822. DOI: 10.7150/thno.80901.


Fully human recombinant antibodies against EphA2 from a multi-tumor patient immune library suitable for tumor-targeted therapy.

Yang Y, Nian S, Li L, Wen X, Liu Q, Zhang B Bioengineered. 2021; 12(2):10379-10400.

PMID: 34709992 PMC: 8810047. DOI: 10.1080/21655979.2021.1996807.


Multiplexed Affinity Characterization of Protein Binders Directly from a Crude Cell Lysate by Covalent Capture on Suspension Bead Arrays.

Huovinen T, Lindenburg L, Minter R, Hollfelder F Anal Chem. 2021; 93(4):2166-2173.

PMID: 33397084 PMC: 7861142. DOI: 10.1021/acs.analchem.0c03992.


Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy.

Maio M, Coukos G, Ferrone S, Fox B, Fridman W, Garcia P Cancer Immunol Immunother. 2018; 68(1):1-9.

PMID: 30564889 PMC: 11028087. DOI: 10.1007/s00262-018-2285-y.


Generation of Novel Anti-MUC1 Monoclonal Antibodies with Designed Carbohydrate Specificities Using MUC1 Glycopeptide Library.

Naito S, Takahashi T, Onoda J, Uemura S, Ohyabu N, Takemoto H ACS Omega. 2018; 2(11):7493-7505.

PMID: 30023556 PMC: 6044872. DOI: 10.1021/acsomega.7b00708.


References
1.
Seurynck-Servoss S, Baird C, Miller K, Pefaur N, Gonzalez R, Apiyo D . Immobilization strategies for single-chain antibody microarrays. Proteomics. 2008; 8(11):2199-210. DOI: 10.1002/pmic.200701036. View

2.
Krebber A, BORNHAUSER S, Burmester J, Honegger A, Willuda J, Bosshard H . Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J Immunol Methods. 1997; 201(1):35-55. DOI: 10.1016/s0022-1759(96)00208-6. View

3.
Ando H, Matsushita T, Wakitani M, Sato T, Kodama-Nishida S, Shibata K . Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo. Biol Pharm Bull. 2008; 31(9):1739-44. DOI: 10.1248/bpb.31.1739. View

4.
Blixt O, Bueti D, Burford B, Allen D, Julien S, Hollingsworth M . Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis. Breast Cancer Res. 2011; 13(2):R25. PMC: 3219186. DOI: 10.1186/bcr2841. View

5.
Kibat J, Schirrmann T, Knape M, Helmsing S, Meier D, Hust M . Utilisation of antibody microarrays for the selection of specific and informative antibodies from recombinant library binders of unknown quality. N Biotechnol. 2015; 33(5 Pt A):574-81. DOI: 10.1016/j.nbt.2015.12.003. View